ESMCOTCElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30
ESCALON MEDICAL CORP
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.18+0.01 (+7.65%)
Close on Oct 19, 2026
- Market cap
- $2.72M
- P/E (TTM)
- 0.7
- Dividend yield
- –
Share price
+$0.0069 (+3.92%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
ESCALON MEDICAL CORP grew revenue 5.7% to $12.74M over the twelve months to Jun 30, 2026. Operating income fell 66.0% to $45.24K, moving the operating margin from 1.1% to 0.4%. Free cash flow was -$407.03K, down 208.0% from a year earlier.
Revenue
$12.74M
+5.7% vs. a year earlier
Operating income
$45.24K
-66.0% vs. a year earlier
Free cash flow
-$407.03K
-208.0% vs. a year earlier
EPS, diluted
$0.27
TTM Q4 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.72M
- P/E ratio
- 0.7
- Price to sales
- 0.21
- Price to book
- 0.46
- Dividend yield
- –
- Free cash flow yield
- -14.97%
Fundamentals
- Revenue
- $12.74M
- Net income
- $4.01M
- EPS, diluted
- $0.27
- Free cash flow
- -$407.03K
- Book value per share
- $0.40
- Diluted shares
- 15M
Fifteen years at a glance
Fiscal years 2012 to 2026, USD
Revenue
$12.74M+5.7% YoY
Gross profit
$5.57M+1.1% YoY
Operating income
$45.24K-66.0% YoY
Net income
$4.01M+3702.5% YoY
EPS, diluted
$0.27
Free cash flow
-$407.03K-208.0% YoY
Reported period